Theraclion Share Price OTC Markets
Stocks
TCLIF
FR0010120402
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5320 USD | +66.25% |
|
-.--% | +66.25% |
| 19/06 | Claude Lenoir appointed interim chairman of Theraclion | |
| 19/06 | Theraclion Chairman Steps Down; Interim Successor Named | MT |
| Market Cap | 4.99Cr 5.68Cr 4.59Cr 4.3Cr 8.06Cr 537.64Cr 8.19Cr 55Cr 21Cr 263.79Cr 21Cr 21Cr 916.85Cr | P/E 2024 |
-2.66x | P/E 2025 | -6.33x |
|---|---|---|---|---|---|
| Enterprise Value | 5.77Cr 6.57Cr 5.32Cr 4.98Cr 9.33Cr 622.31Cr 9.48Cr 64Cr 25Cr 305.34Cr 25Cr 24Cr 1.06TCr | EV / Sales 2024 |
22.5x | EV / Sales 2025 | 55.4x |
| Free-Float |
54.37% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +66.25% | ||
| 3 months | +66.25% | ||
| 6 months | +66.25% | ||
| Current year | +66.25% |
| Current year | 0.53 | 0.53 | |
| 1 year | 0.53 | 0.53 | |
| 3 years | 0 | 0.59 | |
| 5 years | 0 | 2.28 | |
| 10 years | 0 | 2.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Martin Deterre
CEO | Chief Executive Officer | - | 24/05/2023 |
Julie Veisseire
DFI | Director of Finance/CFO | - | - |
Gaylord Tallec
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Renaud Saleur
BRD | Director/Board Member | - | 01/02/2018 |
Ari Kellen
BRD | Director/Board Member | - | 13/02/2019 |
Shawn Langer
BRD | Director/Board Member | - | 13/02/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +66.25% | -.--% | - | - | 5.43Cr | ||
| +1.15% | -0.69% | +17.28% | -10.47% | 17TCr | ||
| +0.06% | -3.33% | -21.73% | +23.20% | 14TCr | ||
| +0.44% | -1.31% | -8.85% | -24.86% | 13TCr | ||
| +2.86% | -2.81% | -55.45% | -15.51% | 6.59TCr | ||
| +1.25% | -1.84% | +15.44% | -3.75% | 4.94TCr | ||
| +0.06% | -2.21% | -25.84% | -32.63% | 4.41TCr | ||
| +0.14% | -1.30% | +9.08% | +6.07% | 3.57TCr | ||
| -0.29% | -0.93% | +4.19% | +37.47% | 3.52TCr | ||
| +5.08% | +0.77% | -10.46% | -20.17% | 2.76TCr | ||
| Average | +7.29% | -1.60% | -8.48% | -4.52% | 7.77TCr | |
| Weighted average by Cap. | +0.55% | -1.98% | -7.27% | -4.71% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 8L 9L 8L 7L 13.42L 8.95Cr 13.64L 91.86L 35.56L 4.39Cr 35.48L 34.71L 15Cr | 7L 7L 6L 6L 10.54L 7.03Cr 10.71L 72.14L 27.92L 3.45Cr 27.86L 27.26L 12Cr |
| Net income | -57.57L -65.53L -53.05L -49.66L -93.04L -62Cr -94.61L -6.37Cr -2.47Cr -30Cr -2.46Cr -2.41Cr -105.86Cr | -56.9L -64.77L -52.43L -49.08L -91.96L -61Cr -93.51L -6.3Cr -2.44Cr -30Cr -2.43Cr -2.38Cr -104.63Cr |
| Net Debt | 34.11L 38.82L 31.43L 29.42L 55.12L 37Cr 56.05L 3.77Cr 1.46Cr 18Cr 1.46Cr 1.43Cr 63Cr | 78.52L 89.38L 72.35L 67.73L 1.27Cr 85Cr 1.29Cr 8.69Cr 3.36Cr 42Cr 3.36Cr 3.28Cr 144.39Cr |
Employees
36
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALTHE Stock
- TCLIF Stock
Select your edition
All financial news and data tailored to specific country editions
















